Advertisement
Screener

Prosight Management, LP Historic Quarter Change: USA Other Stocks, Sold Out

Prosight Management, LP historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Prosight Management, LP opened 5 positions, added to 2, reduced 4 and sold out of 8.

  • Q2 2025: Stock BLUEPRINT MEDICINES CORP; Country of operation United States; Class COM; Shares before 36,512.
  • Q4 2024: Stock ACCOLADE INC; Country of operation United States; Class COM; Shares before 2,801,598.
  • Q4 2024: Stock VINCERX PHARMA INC; Country of operation United States; Class COM NEW; Shares before 2,206,505.
  • Q3 2024: Stock PARAGON 28 INC; Country of operation United States; Class COM; Shares before 261,400.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1617201), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2017-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025BLUEPRINT MEDICINES CORP
CUSIP 09627Y109
United StatesCOM36,5120-36,512$3,231,677$0-$3,231,6772025-08-14
Q4 2024ACCOLADE INC
CUSIP 00437E102
United StatesCOM2,801,5980-2,801,598$10,786,152$0-$10,786,1522025-02-14
Q4 2024VINCERX PHARMA INC
CUSIP 92731L106
United StatesCOM NEW2,206,5050-2,206,505$1,579,858$0-$1,579,8582025-02-14
Q3 2024PARAGON 28 INC
CUSIP 69913P105
United StatesCOM261,4000-261,400$1,787,976$0-$1,787,9762024-11-14
Q3 2024KEZAR LIFE SCIENCES INC
CUSIP 49372L100
United StatesCOM56,0800-56,080$33,648$0-$33,6482024-11-14
Q2 2024AVROBIO INC
CUSIP 05455M100
United StatesCOM566,5190-566,519$725,144$0-$725,1442024-08-14
Q1 2024GRAPHITE BIO
CUSIP 38870X104
United StatesCOM1,351,9390-1,351,939$3,542,080$0-$3,542,0802024-05-15
Q1 2024SHOCKWAVE MEDICAL
CUSIP 82489T104
United StatesCOM5,0000-5,000$952,800$0-$952,8002024-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
Pandi, LLCUnited States$0.610B4
Blue Fin Capital, Inc.United States$0.610B150
Armbruster Capital Management, Inc.United States$0.610B132
DGS Capital Management, LLCUnited States$0.609B630
STRATEGY ASSET MANAGERS LLCUnited States$0.609B263
Citizens Business BankUnited States$0.610B229
AMERICAN INTERNATIONAL GROUP, INC.United States$0.609B2
FRG Family Wealth Advisors LLCUnited States$0.611B157
IFG Advisors, LLCUnited States$0.611B149
Convergence Investment Partners, LLCUnited States$0.611B235